The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort
Nephrology · 2023-06 · 28 (6) · 328-335
DOI: 10.1111/nep.14160 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Nephrology, online erschienen am 19.04.2023. Verfasst von Georgina L Irish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Aust…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Kidney Failure, Chronic, Renal Insufficiency. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Royal Australasian College of Physicians, Royal Hobart Hospital Research Foundation.
Abstract (Originalsprache)
Aims
Predicting progression to kidney failure for patients with chronic kidney disease is essential for patient and clinicians' management decisions, patient prognosis, and service planning. The Tangri et al Kidney Failure Risk Equation (KFRE) was developed to predict the outcome of kidney failure. The KFRE has not been independently validated in an Australian Cohort.
Methods
Using data linkage of the Tasmanian Chronic Kidney Disease study (CKD.TASlink) and the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), we externally validated the KFRE. We validated the 4, 6, and 8‐variable KFRE at both 2 and 5 years. We assessed model fit (goodness of fit), discrimination (Harell's C statistic), and calibration (observed vs predicted survival).
Results
There were 18 170 in the cohort with 12 861 participants with 2 years and 8182 with 5 years outcomes. Of these 2607 people died and 285 progressed to kidney replacement therapy. The KFRE has excellent discrimination with C statistics of 0.96–0.98 at 2 years and 0.95–0.96 at 5 years. The calibration was adequate with well‐performing Brier scores (0.004–0.01 at 2 years, 0.01–0.03 at 5 years) however the calibration curves, whilst adequate, indicate that predicted outcomes are systematically worse than observed.
Conclusion
This external validation study demonstrates the KFRE performs well in an Australian population and can be used by clinicians and service planners for individualised risk prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.
- Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
- Department of Medicine, The University of Adelaide, Adelaide, Australia.
- School of Medicine, University of Tasmania, Australia.
- Renal Unit, Royal Hobart Hospital, Tasmanian Health Service, Tasmania, Australia.
ORCID-Profile: Georgina L Irish, Matthew D Jose
Förderung
- National Health and Medical Research Council
- Royal Australasian College of Physicians
- Royal Hobart Hospital Research Foundation
- Tasmanian Community Fund
Zitieren
APA
Irish, G. L., Cuthbertson, L., Kitsos, A., Saunder, T., Clayton, P. A., & Jose, M. D. (2023). The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort. Nephrology, 28(6), 328-335. https://doi.org/10.1111/nep.14160
Vancouver
Irish GL, Cuthbertson L, Kitsos A, Saunder T, Clayton PA, Jose MD. The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort. Nephrology. 2023;28(6):328-335. doi:10.1111/nep.14160
BibTeX
@article{Irish2023,
author = {Irish, Georgina L and Cuthbertson, Laura and Kitsos, Alex and Saunder, Tim and Clayton, Philip A and Jose, Matthew D},
title = {The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort},
journal = {Nephrology},
year = {2023},
volume = {28},
number = {6},
pages = {328--335},
doi = {10.1111/nep.14160}
}
EUVIMED